139 related articles for article (PubMed ID: 8799202)
1. The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes.
Nottet HS; Flanagan EM; Flanagan CR; Gelbard HA; Gendelman HE; Reinhard JF
J Neurovirol; 1996 Apr; 2(2):111-7. PubMed ID: 8799202
[TBL] [Abstract][Full Text] [Related]
2. Quinolinic acid production is related to macrophage tropic isolates of HIV-1.
Brew BJ; Corbeil J; Pemberton L; Evans L; Saito K; Penny R; Cooper DA; Heyes MP
J Neurovirol; 1995 Dec; 1(5-6):369-74. PubMed ID: 9222379
[TBL] [Abstract][Full Text] [Related]
3. Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia.
Xiong H; Zeng YC; Zheng J; Thylin M; Gendelman HE
J Neurovirol; 1999 Oct; 5(5):519-28. PubMed ID: 10568889
[TBL] [Abstract][Full Text] [Related]
4. Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha.
Pemberton LA; Kerr SJ; Smythe G; Brew BJ
J Interferon Cytokine Res; 1997 Oct; 17(10):589-95. PubMed ID: 9355959
[TBL] [Abstract][Full Text] [Related]
5. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.
Smith DG; Guillemin GJ; Pemberton L; Kerr S; Nath A; Smythe GA; Brew BJ
J Neurovirol; 2001 Feb; 7(1):56-60. PubMed ID: 11519483
[TBL] [Abstract][Full Text] [Related]
6. Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages.
Kerr SJ; Armati PJ; Pemberton LA; Smythe G; Tattam B; Brew BJ
Neurology; 1997 Dec; 49(6):1671-81. PubMed ID: 9409365
[TBL] [Abstract][Full Text] [Related]
7. CPI-1189 attenuates effects of suspected neurotoxins associated with AIDS dementia: a possible role for ERK activation.
Pulliam L; Irwin I; Kusdra L; Rempel H; Flitter WD; Garland WA
Brain Res; 2001 Mar; 893(1-2):95-103. PubMed ID: 11222997
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical localization of the endogenous neuroexcitotoxin quinolinate in human peripheral blood monocytes/macrophages and the effect of human T-cell lymphotropic virus type I infection.
Venkateshan CN; Narayanan R; Espey MG; Moffett JR; Gajdusek DC; Gibbs CJ; Namboodiri MA
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1636-41. PubMed ID: 8643683
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains.
Achim CL; Heyes MP; Wiley CA
J Clin Invest; 1993 Jun; 91(6):2769-75. PubMed ID: 8514884
[TBL] [Abstract][Full Text] [Related]
10. Increased quinolinate immunoreactivity in the peripheral blood monocytes/macrophages from SIV-infected monkeys.
Namboodiri AM; Venkateshan CN; Narayanan R; Blinder K; Moffett JR; Gajdusek DC; Gravell M; Gibbs CJ
J Neurovirol; 1996 Dec; 2(6):433-8. PubMed ID: 8972426
[TBL] [Abstract][Full Text] [Related]
11. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
Valle M; Price RW; Nilsson A; Heyes M; Verotta D
Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
[TBL] [Abstract][Full Text] [Related]
12. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes.
Nottet HS; Jett M; Flanagan CR; Zhai QH; Persidsky Y; Rizzino A; Bernton EW; Genis P; Baldwin T; Schwartz J
J Immunol; 1995 Apr; 154(7):3567-81. PubMed ID: 7897236
[TBL] [Abstract][Full Text] [Related]
13. [Encephalopathy in AIDS--increased formation of beta-chemokines in monocytes after HIV-1 virus infection: mechanisms of CNS involvement].
Mayer V; Schmidtmayerová H
Bratisl Lek Listy; 1997 Jun; 98(6):330-4. PubMed ID: 9333424
[TBL] [Abstract][Full Text] [Related]
14. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.
Guillemin GJ; Smythe G; Takikawa O; Brew BJ
Glia; 2005 Jan; 49(1):15-23. PubMed ID: 15390107
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus encephalitis in SCID mice.
Persidsky Y; Limoges J; McComb R; Bock P; Baldwin T; Tyor W; Patil A; Nottet HS; Epstein L; Gelbard H; Flanagan E; Reinhard J; Pirruccello SJ; Gendelman HE
Am J Pathol; 1996 Sep; 149(3):1027-53. PubMed ID: 8780406
[TBL] [Abstract][Full Text] [Related]
16. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
17. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease.
Bukrinsky MI; Nottet HS; Schmidtmayerova H; Dubrovsky L; Flanagan CR; Mullins ME; Lipton SA; Gendelman HE
J Exp Med; 1995 Feb; 181(2):735-45. PubMed ID: 7530762
[TBL] [Abstract][Full Text] [Related]
18. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.
Yoshioka M; Bradley WG; Shapshak P; Nagano I; Stewart RV; Xin KQ; Srivastava AK; Nakamura S
Adv Neuroimmunol; 1995; 5(3):335-58. PubMed ID: 8748077
[TBL] [Abstract][Full Text] [Related]
19. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.
Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ
J Neurochem; 2001 Aug; 78(4):842-53. PubMed ID: 11520905
[TBL] [Abstract][Full Text] [Related]
20. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.
Lipton SA
Mol Neurobiol; 1994; 8(2-3):181-96. PubMed ID: 7999315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
